Deep Patent & Trial Experience
Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.
We participated in the representation of Ariad, obtaining a $65 million jury verdict for infringement of our client’s patents for regulating NF-kappaB cell-signaling activity, the largest verdict in Massachusetts that year.
Exergen Corporation vs. Kaz, USA, Inc.
Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.
FairWarning IP, LLC v. Iatric, Inc.; FairWarning IP, LLC v. CynergisTek, Inc.
In both the District Court and at the Federal Circuit Court of Appeals, Sunstein successfully defended clients Iatric and CynergisTek against claims of patent infringement relating to software for detecting fraud and misuse of protected health information, obtaining judgments of patent invalidity under Section 101.
In disputes over brand names, we have also delivered major successes to our clients.
Winning at Post Grant Proceedings
Motorola Mobility LLC, Google Inc., and Apple Inc. v. Arendi S.A.R.L.
Motorola, Google and Apple attacked the same patent as Samsung raising several additional grounds. Our arguments carried the day and the inter partes review was not instituted, freeing our client’s patent for unfettered assertion in court.
Spotlight on Patents
A recent patent we obtained for our client Nexsan, of Santa Clara, CA, U.S. Patent No. 9218406 covers a private cloud storage system in which security is maintained by storing the data on devices (sold under the Transporter brand) of individual users. Data is shared on a peer-to-peer basis. A central server governs access based on user privileges without storing any of the shared data. This patent has issued in one of the fields in which recent court rulings have been propelling rapid evolution of the law.
In the News
Sunstein attorneys “Walk to the Hill” to support legal aid funding. Click here for more re the event.
(l to r) Lena Cavallo, Sharona Sternberg, Lisa Tittemore, Kerry Timbers, Erin Connors, Arne Hans
Winning Patents! Patents we prosecuted resulted in our client, Conformis, obtaining a $10.5 million Settlement. More…
14 Sunstein attorneys named to the Super Lawyers and Rising Stars 2018 roster. More…
Lisa Tittemore, SUNSTEIN Litigation Group Co-Chair, was a member of the committee that drafted extensive revisions to Local Rule 16.6, adopted by the U.S. District Court for D.MA effective June 1, 2018. It is anticipated that the new rule will make the court a more appealing venue for patent litigation.
SUNSTEIN’s Federal Circuit Win in Exergen: Diagnostic Patents Survive Eligibility Challenge
This is the first Federal Circuit decision upholding the patentability of a diagnostic patent since the Supreme Court struck down a diagnostic invention on patent eligibility grounds in Mayo v. Prometheus in 2012. More. . . Law360 Article
SUNSTEIN has been named a Tier 1 firm in Boston for Litigation – Intellectual Property by U.S. News – Best Lawyers® “Best Law Firms” in 2019.
SUNSTEIN has been named a Recommended Firm by Chambers® in 2018.
Sunstein successfully represented long-time client ’47 before USPTO’s TTAB preventing adversary’s registration of a 47 in a circle. Read more here.
Our Latest Thinking
To sue for copyright infringement, you must first register your copyright; merely applying is not enough, says Supreme Court. Fourth Estate v. Wall-Street.com. More...
Despite a statutory phrase indicating otherwise, the litigation costs that a court may award to a successful copyright plaintiff don’t exceed the usual, says Supreme Court. Rimini Street v. Oracle. More...
The Federal Circuit reminds us that even brilliant diagnostic inventions may be patent-ineligible when routine and conventional steps are used to apply a disease-related correlation. Athena Diagnostics v. Mayo Collaborative Services. More...
Secret sales of one’s invention trigger the patent law’s one-year on-sale bar, the Supreme Court now clarifies. Helsinn Healthcare v. Teva Pharmaceuticals. More...
The efficiencies that Europe has introduced to privacy regulation may be unavailable to US companies. More...